1. Market Research
  2. > Advanced IT Market Trends
Ambitions in Health: Tech companies step up the pace

Ambitions in Health: Tech companies step up the pace

  • January 2018
  • ID: 5355973
  • Format: PDF
  • By Firstword Pharma


Table of Contents

As investment $$$ pour into digital health projects, the scope and scale of tech giants’ ambitions in health become ever clearer. From drug discovery and clinical research to patient monitoring and disease management, tech giants are leveraging the latest advances in artificial intelligence (AI), deep learning, analytics and wearable technology to drive innovation and disrupt processes. How can pharma respond and what strengths does it have that tech companies need?
This expert report draws on the insights of 15 digital health experts in pharma, consulting and tech companies to give a unique and comprehensive analysis of the current and future digital health landscape and the role tech companies will play.

Discover on this page…
• Why this report is important to you
• What the report will enable you to do
• Full Report Contents

Why this report is important to you

Global technology giants are the most valuable companies on the Standard and Poor’s 500 Index, and they are making big bets in healthcare. These companies’ technologies and consumer expertise are poised to transform an industry ripe for disruption through telemedicine, data mobility, cloud computing, wearables, artificial intelligence, big data and the empowered consumer/patient. In contrast to the fast moving digital sector, the risk adverse and heavily regulated pharma industry is looking out of time and place. Can pharma change its slow, legacy culture; adopt new technologies for efficiency; work collaboratively across silos, and attract the best talent? Pharma needs to collaborate with tech companies as much as tech companies need pharma’s unique set of skills. There are opportunities a plenty for those companies wishing to embrace change.

With focus on…
• Apple
• Alphabet/Google/Verily
• Amazon
• Microsoft
• Facebook
• Samsung

This report will enable you to…
• Understand the drivers of tech giant expansion into health and identify where their interests lay
• Know what digital technologies will most benefit pharma, and why
• Appreciate how demanding tech savvy patients are changing the healthcare landscape
• Play to your drug development, regulatory, production, marketing and market access strengths when partnering with tech companies
• Compete effectively with tech companies for digital, analytical and AI talent
• Challenge and replace slow moving siloed corporate structures that are not fit for purpose in a digital world
• Know where digital health is most likely to disrupt pharma’s operations and respond with progressive strategies

Report Contents
Executive summary
Research objectives and methodology
Experts interviewed

The digital transformation of health
• Key insights
• Digital health trends and funding
• Tech giants lead the global economy, making big bets in healthcare
• What is driving technology giants’ expansion into digital health and life sciences?
• What digital health areas are being targeted by tech giants?
• Are big tech companies vying for the same opportunities?
• Is any tech company poised to become a dominant force in digital health?
• Tech giants’ activities in healthcare and life sciences
• Apple
• Alphabet/Google/Verily
• Amazon
• Microsoft
• Facebook
• Samsung
• Who are the tech companies’ healthcare customers?
• Consumers in the digital health transformation
• Consumer trust in tech companies
• Digitally-savvy millennials moving up the ranks of healthcare
• Engaging an ageing population in digital health
• Tech-enabled consumers reordering the healthcare landscape
• The evolving role of the patient

Tech giants changing the healthcare landscape
• Key insights
• How are tech giants changing the healthcare landscape?
• How might these changes affect key healthcare stakeholders?
• Opportunities for pharma in a health landscape driven by tech company innovation
• Are tech giants looking to advance their own initiatives or form partnerships?
• Partnering for success
• What threats does a bigger tech presence in healthcare pose for the pharma industry?
• In what areas are tech companies at a disadvantage in digital health?
• What’s holding pharma back in the digital health transformation?
• Regulatory and policy changes
• Regulatory challenges tech companies face
• FDA PreCert pilot programme for software developers
• What is the reaction to the FDA PreCert programme?
Talent trends: competing in science and technology
Key insights

Tech giant hiring trends
• Alphabet/Google
• Apple
• Amazon
• Microsoft
• Facebook
• Oracle
• Pharma competing for digital, analytical and AI talent

The future
• Key Insights
• Artificial Intelligence (AI) and the future of drug discovery
• Understanding AI and its subsectors
• Tech giants’ AI leaders remain tied to academia
• Future opportunities for AI-led technologies in healthcare and pharma
• Competing with tech giants for AI technology

The next five years
• How will tech companies change the delivery of healthcare?
• Where is the future value for pharma in partnering with tech companies?
• Closing thoughts

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.
Ahmad helps you find the right report:

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at researchadvisor@reportlinker.com to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - researchadvisor@reportlinker.com or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers
AI in the Future of Workspace: Five Work Scenarios on the Near to Midterm Horizon

AI in the Future of Workspace: Five Work Scenarios on the Near to Midterm Horizon

  • $ 4500
  • January 2020

This IDC study discusses how technologies in the AI family have or will become a catalyst to make the future workspace more secure, flexible, collaborative, and productive. According to Jessie Cai Danqing, ...

Asia/Pacific (Excluding Japan) Internet of Things Spending 1H19 Forecast Update

Asia/Pacific (Excluding Japan) Internet of Things Spending 1H19 Forecast Update

  • $ 4500
  • January 2020

The IoT enterprise market is being driven by a combination of advances in sensor and device processor cost performance, the DX of services, the explosive growth of cloud services, the introduction of artificial ...

IoT in Chemical Industry Market by Technology Type, Chemical Verticals, Region - Global Forecast to 2024

IoT in Chemical Industry Market by Technology Type, Chemical Verticals, Region - Global Forecast to 2024

  • $ 4950
  • January 2020

Increasing emphasis on technology for various industrial applications is expected to drive the IoT in Chemical Industry market.The IoT in Chemical Industry market is estimated to grow from USD 48.9 billion ...


Reportlinker.com © Copyright 2020. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on